Cargando…
Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
BACKGROUND: Persistence is a key factor for long-term blood pressure control, which is of high prognostic importance for patients at increased cardiovascular risk. Here we present the results of a post-marketing survey including 4769 hypertensive patients treated with irbesartan in 886 general pract...
Autores principales: | Burnier, Michel, Hess, Bernhard, Greminger, Peter, Waeber, Bernard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166543/ https://www.ncbi.nlm.nih.gov/pubmed/15943871 http://dx.doi.org/10.1186/1471-2261-5-13 |
Ejemplares similares
-
Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011) -
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009) -
Critical review of cancer risk associated with angiotensin receptor blocker therapy
por: Wuerzner, Grégoire, et al.
Publicado: (2011) -
Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006) -
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)